| 1st Dec 2015 1:09 pm |
RNS |
Total Voting Rights |
| 13th Nov 2015 2:14 pm |
RNS |
Director/PDMR Shareholding |
| 12th Nov 2015 3:41 pm |
RNS |
Blocklisting Interim Review |
| 11th Nov 2015 3:10 pm |
RNS |
Director/PDMR Shareholding |
| 5th Nov 2015 7:00 am |
RNS |
GSK's Nucala® receives approval from US FDA |
| 3rd Nov 2015 11:56 am |
RNS |
ViiV Healthcare announces positive results |
| 3rd Nov 2015 11:56 am |
RNS |
GSK profiles innovative R&D portfolio to investors |
| 2nd Nov 2015 12:45 pm |
RNS |
Director Declaration |
| 2nd Nov 2015 10:31 am |
RNS |
Total Voting Rights |
| 29th Oct 2015 3:39 pm |
RNS |
Director/PDMR Shareholding |
| 28th Oct 2015 12:00 pm |
RNS |
3rd Quarter Results |
| 28th Oct 2015 7:00 am |
RNS |
GSK Exercises Option on OXB LentiVector Patents |
| 27th Oct 2015 10:50 am |
RNS |
Results of LABA safety study for Advair Diskus |
| 27th Oct 2015 10:50 am |
RNS |
90% efficacy in shingles vaccine for over 70's |
| 20th Oct 2015 4:57 pm |
RNS |
Director/PDMR Shareholding |
| 20th Oct 2015 4:52 pm |
RNS |
Director/PDMR Shareholding |
| 20th Oct 2015 1:20 pm |
RNS |
Director/PDMR Shareholding |
| 20th Oct 2015 1:14 pm |
RNS |
Director/PDMR Shareholding |
| 20th Oct 2015 1:02 pm |
RNS |
Positive Data for Incruse Ellipta Comparisons |
| 19th Oct 2015 2:38 pm |
RNS |
Director/PDMR Shareholding |
| 19th Oct 2015 2:36 pm |
RNS |
Director/PDMR Shareholding |
| 19th Oct 2015 2:34 pm |
RNS |
Director/PDMR Shareholding |
| 13th Oct 2015 1:54 pm |
RNS |
Director/PDMR Shareholding |
| 12th Oct 2015 4:52 pm |
RNS |
Director/PDMR Shareholding |
| 8th Oct 2015 12:29 pm |
RNS |
Director/PDMR Shareholding |
| 7th Oct 2015 12:26 pm |
RNS |
Director/PDMR Shareholding |
| 5th Oct 2015 10:00 am |
RNS |
Director/PDMR Shareholding |
| 2nd Oct 2015 2:35 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Oct 2015 2:32 pm |
RNS |
Director/PDMR Shareholding |
| 1st Oct 2015 12:07 pm |
RNS |
Director/PDMR Shareholding |
| 1st Oct 2015 9:58 am |
RNS |
Total Voting Rights |
| 30th Sep 2015 1:40 pm |
RNS |
Director/PDMR Shareholding |
| 28th Sep 2015 4:54 pm |
RNS |
Director/PDMR Shareholding |
| 24th Sep 2015 2:54 pm |
RNS |
CHMP opinion for mepolizumab (Nucala) in Europe |
| 24th Sep 2015 8:03 am |
RNS |
Intention to file Relvar Ellipta for COPD in Japan |
| 23rd Sep 2015 8:30 am |
RNS |
ViiV Healthcare Phase lllb/IV STRIIVING data |
| 17th Sep 2015 12:13 pm |
RNS |
Director/PDMR Shareholding |
| 14th Sep 2015 3:52 pm |
RNS |
Director/PDMR Shareholding |
| 10th Sep 2015 1:06 pm |
RNS |
Director/PDMR Shareholding |
| 9th Sep 2015 7:00 am |
RNS |
Results from the SUMMIT COPD CV Survival Study |
